Skip to main content

Month: May 2023

Lincoln Electric Awarded on the USA Today America’s Climate Leaders 2023 List

CLEVELAND, May 25, 2023 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) is pleased to announce that it has been awarded on the USA Today list of America’s Climate Leaders 2023. This inaugural award is presented by USA Today and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list can be viewed on the USA Today website. USA Today’s America’s Climate Leaders 2023 List represents the leading 400 companies across the United States that achieved the greatest reduction in their core emissions intensity between 2019 and 2021, as calculated by their Scope 1 and 2 greenhouse gas emissions as a ratio of revenue. Lincoln Electric was one of 31 companies awarded within the Capital Goods category. “We are pleased to be named as one of America’s Climate Leaders,...

Continue reading

Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101

– Initial Data from Global, Multiple Ascending Dose Phase 1/2 ACHIEVE Clinical Trial in Myotonic Dystrophy Type 1 Anticipated in the Second Half of 2023 – WALTHAM, Mass., May 25, 2023 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that the European Medicines Agency (EMA) has granted orphan drug designation for DYNE-101. DYNE-101 is being evaluated in the Phase 1/2 ACHIEVE global clinical trial in adults with myotonic dystrophy type 1 (DM1). “We are pleased to receive orphan drug designation from the EMA for DYNE-101, further supporting our efforts to develop a potentially transformative therapy for DM1,” said Wildon Farwell, M.D., MPH, chief...

Continue reading

CSW Industrials Reports Record Fiscal 2023 Fourth Quarter and Full Year Results

DALLAS, May 25, 2023 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (Nasdaq: CSWI or the “Company”) today reported record results for the fiscal 2023 fourth quarter and full year periods ended March 31, 2023. Fiscal 2023 Fourth Quarter Highlights (comparisons to fiscal 2022 fourth quarter)Total revenue increased 12.9% to $195.7 million, with an organic growth rate of 10.5% Net income attributable to CSWI increased 46.7% to $27.1 million, compared to $18.4 million, with no adjustments to earnings in either period Earnings per diluted share (EPS) increased 48.7% to $1.74, compared to $1.17 EBITDA increased 32.8% to $49.4 million, with margin expansion of 370 bps to 25.2% Paid down $23.5 million of debt and improved balance sheet strength with a leverage ratio (Debt to EBITDA), in accordance with our credit facility, of approximately...

Continue reading

FRO – Invitation to Q1 2023 Results Conference Call and Webcast

Frontline plc.’s preliminary first quarter 2023 results will be released on Wednesday May 31, 2023, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontlineplc.cy ahead of the conference call.  In order to attend the conference call you may do one of the following: a. WebcastGo to the Investor Relations section at www.frontlineplc.cy and follow the “Webcast” link, or access directly from the link below. Frontline plc Q1 2023 Webcast b. Conference Call Participants will need to register online prior to the conference call via the link below. Dial-in details will be available when registered.               Frontline plc Q1 2023 Conference Call A Q&A session will be held after the teleconference/webcast....

Continue reading

Result of auction of mortgage covered bonds (SDRO’s) in series 11F, 12E, 12F and 12G

To NASDAQ Copenhagen A/S   Executive Board Lersø Parkalle 100 DK-2100 København Ø www.rd.dk Telephone +45 7012 5300 25 May 2023Company announcement number 42/2023 Result of auction of mortgage covered bonds (SDRO’s) in series 11F, 12E, 12F and 12GToday, Realkredit Danmark has completed the auctions of mortgage covered bonds (SDRO’s) in series 11F, 12E, 12F and 12G for the refinancing of FlexKort®, RD Cibor6® Green, RD Cibor6® and RD Euribor3® as of 1 July 2023. The result of the auctions is set out in the appendix to this announcement.   The Executive Board Any additional questions should be addressed to Christian Rosenstand, Head of RD Funding, phone +45 45 13 20 19.AttachmentsNr. 42_Resultat af auktioner over obligationer_ukBilag til selskabsmeddelelse nr. 42-2023_uk

Continue reading

NIO Inc. to Hold Annual General Meeting on June 26, 2023

SHANGHAI, China, May 25, 2023 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today published a notice to announce that it will hold an annual general meeting (the “AGM”) of shareholders (the “Notice of AGM”) at 10:30 am, Beijing time, on June 26, 2023 at Building 19, No. 889, Tianlin Road, Minhang District, Shanghai, People’s Republic of China, for the purposes of considering and, if thought fit, passing the proposed resolutions set forth in the Notice of AGM (the “Proposed Resolutions”). The Notice of AGM and form of proxy for the AGM are available on the Company’s website at https://ir.nio.com/generalmeeting. The board of directors of NIO fully supports the Proposed Resolutions and recommends that shareholders...

Continue reading

Brown & Brown, Inc. announces the appointment of Pattysue Rauh as chief audit officer

DAYTONA BEACH, Fla., May 25, 2023 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE:BRO) (the “Company”) has announced the appointment of Pattysue Rauh as chief audit officer for Brown & Brown, effective July 2023. Rauh will also serve on the senior leadership team. In this new role, Rauh will lead the Company’s internal audit and compliance operations, overseeing internal controls. She will transition from her current role as executive vice president of national employee benefits within Brown & Brown’s Retail segment over the coming month. Andy Watts, chief financial officer, said, “Pattysue has been a valuable part of the Brown & Brown team for more than 25 years. She has served in various roles, including marketing, production, office leadership, and most recently, as part of the leadership team driving the continued...

Continue reading

Burlington Stores, Inc. Reports First Quarter 2023 Earnings

On a GAAP basis, total sales increased 11% Net income was $33 million, and diluted EPS was $0.50 Comparable store sales increased 4% On a non-GAAP basis, Adjusted EBIT was $87 million, and Adjusted EPS was $0.84BURLINGTON, N.J., May 25, 2023 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, today announced its results for the first quarter ended April 29, 2023.   Michael O’Sullivan, CEO, stated, “Our first quarter comparable sales growth came in just below guidance. We had gotten off to a very strong start but then the trend fell off in March. We believe that this weakening in the trend was driven by two external and transitory factors – lower tax refunds and cooler...

Continue reading

Titan Machinery Inc. Announces Results for Fiscal First Quarter Ended April 30, 2023

– Revenue for First Quarter of Fiscal 2024 Increased 23.6% to $569.6 million – – First Quarter of Fiscal 2024 EPS Increased 55% to $1.19 – – Reiterates Fiscal 2024 EPS Modeling Assumption Range of $4.50-$5.10 – WEST FARGO, N.D., May 25, 2023 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, today reported financial results for the fiscal first quarter ended April 30, 2023. David Meyer, Titan Machinery’s Chairman and Chief Executive Officer, stated, “We are off to a solid start to fiscal 2024 with strong first quarter results consistent with our expectations going into the year. Notably, each of our operating segments achieved expansion in pre-tax margins versus the prior year period. Our Agriculture...

Continue reading

Adverum Biotechnologies Announces New Executive Leadership Roles

– Richard Beckman, M.D., chief medical officer, transitions to senior medical advisor – – Star Seyedkazemi, Pharm.D., chief development officer, expands her responsibilities to lead Adverum’s clinical development, medical affairs and pharmacovigilance teams – REDWOOD CITY, Calif., May 25, 2023 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced new executive leadership roles that support the ongoing development of the investigational gene therapy ixoberogene soroparvovec (Ixo-vec). Ixo-vec is currently being evaluated in the Phase 2 LUNA trial as a one-time intravitreal (IVT) injection for patients in the treatment of neovascular or wet age-related macular...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.